As the biopharmaceutical landscape continues to evolve, peptide and oligonucleotide therapeutics are gaining unprecedented momentum. These complex molecules are at the forefront of the next generation of targeted therapies, offering promising treatments for a variety of diseases, including cancer, cardiovascular conditions, and rare genetic disorders. However, the path from discovery to market for these therapeutics is fraught with unique challenges, particularly in terms of synthesis, scalability, regulatory approval, and commercialization. TIDES of Innovation will address these challenges through specialized, high-level discussions on optimizing synthesis, navigating regulatory landscapes, and developing effective strategies for commercial scale-up.

Panel Discussion

CPC Scientific is proud to be an Associate Sponsor at TIDES of Innovation. Join us on September 10 for “Peptide Cancer Vaccines: From Bench Formulation to GMP Reality”, a thought-provoking panel discussion moderated by Clàudia Badia i Lopez.

Discover how advances in peptide formulation, process development, and GMP manufacturing are accelerating the translation of cancer vaccine research into clinical reality. Don’t miss the chance to hear from leading experts shaping the future of peptide and oligo therapeutics!

Time: September 10 | 4:05 – 4:30 PM

Appointment Request

We would love to meet with you to discuss your peptide or oligonucleotide API projects. We will be exhibiting at Booth #10; please schedule an appointment below to meet our team at the TIDES of Innovation in Amsterdam.